Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-10-22-Speech-2-020"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2002-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Medicinal products2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20021022.1.2-020"2
lpv:hasSubsequent	lp_eu:2002-10-22-Speech-2-0212
lpv:speaker	lp:Phillip Whitehead2
lpv:spoken text	"Mr President, in this brief time I would like to make two points, both in relation to veterinary medicines. In a way, they have been the poor relation in these debates because of the immense complexity of the situation with regard to human medicinal substances. Firstly, I would like to warn against the Commission's proposals under Article 67 that all veterinary medicines intended for food-producing animals should be available on prescription only. Some Member States, including my own, have a well-established distribution system that allows medicines for which veterinary involvement is not considered necessary for safe and effective use to be obtained without a veterinary certificate. I can see why some professional organisations in some other Member States would be opposed to that, but it has worked effectively for very many years in Ireland as well as the UK. When we now look at the enlargement of the Union, all kinds of problems will arise if we allow ourselves now to move towards a centralised system which allows only by prescription use of such medicines as are currently administered by qualified persons in countries like the UK. I therefore commend Amendment No 43 to the House. My second and last point is that on the mandatory centralised procedures proposed by the Commission, the committee decided to move to a more flexible system for human medicines, but did not follow that same route in terms of animal medicines. We should rectify that and we can do so through Amendment No 171. Finally, I would make the point that it is a mistake for the Commission to propose that we remove the five-year renewal requirement for marketing authorisation. That is a safety precaution we should retain."@en1
lpv:spokenAs	member; PES (1999-07-20--2004-07-19)3 member; Delegation to the EU-Czech Republic Joint Parliamentary Committee (2002-02-07--2004-04-30)3 member; Committee on the Environment, Public Health and Consumer Policy (2002-01-17--2004-07-19)3 unknown; Labour Party (1999-07-20--2004-07-19)3 member; Temporary committee on foot and mouth disease (2002-01-17--2002-12-17)3 substitute; Committee on Culture, Youth, Education, the Media and Sport (2002-01-17--2004-07-19)3
lpv:unclassifiedMetadata	"Whitehead (PSE )."1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph